The Speculator (David Haselhurst) in today's Bulletin magazine has picked VLA as a strong buy recommendation.
The write-up is exceptionally robust by Haselhurst's normally fairly subdued standards.
(Can't give you a link - it isn't on the Internet yet. However the mag has just hit the newsstands.)
As a one-time medical writer/researcher, I can verify that novel cancer-fighting technologies are thin on the ground. VLA's has much promise.
Haselhurst points out (correctly IMO) that this is a sitting duck for a takeover right now, and one of the big pharmaceutical companies could snap it up "out of the petty cash tin".
With VLA still so cheap and its product looking strong (with new results round the corner), this seems to me a fairly strong buy right now.
- Forums
- ASX - By Stock
- VLA
- viralytics is the speculators buy of the week
viralytics is the speculators buy of the week
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online